Name | methyl 7-hydroxy-5-oxo-2,3-dihydro-1H-indolizine-8-carboxylate |
---|---|
Synonyms |
7-hydroxy-5-oxo-1,2,3,5-tetrahydro-indolizine-8-carboxylic acid methyl ester
8-ethoxycarbonyl-7-hydroxy-2,3-dihydro-1H-indolizin-5-one methyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate HMS1732K08 |
Density | 1.42g/cm3 |
---|---|
Boiling Point | 362.6ºC at 760 mmHg |
Molecular Formula | C10H11NO4 |
Molecular Weight | 209.19900 |
Flash Point | 173.1ºC |
Exact Mass | 209.06900 |
PSA | 68.53000 |
LogP | 0.28670 |
Index of Refraction | 1.605 |
Storage condition | 2-8°C |
HS Code | 2933990090 |
---|
~74% 37704-45-3 |
Literature: TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent: US2009/124595 A1, 2009 ; Location in patent: Page/Page column 33 ; US 20090124595 A1 |
Precursor 2 | |
---|---|
DownStream 1 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |